Correction To: Analysis of Autonomic Outcomes in APOLLO, a Phase III Trial of the RNAi Therapeutic Patisiran in Patients With Hereditary Transthyretin-Mediated Amyloidosis
Journal of Neurology - Germany
doi 10.1007/s00415-020-09715-5
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 7, 2020
Authors
Publisher
Springer Science and Business Media LLC